B-type Natriuretic Peptide (BNP) Quality Control - NMPA Registration 粤械注准20242401696
Access comprehensive regulatory information for B-type Natriuretic Peptide (BNP) Quality Control in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 粤械注准20242401696 and owned by Guangzhou Wondfo BIOTECH Co., Ltd.. The device was approved on December 19, 2024.
This page provides complete registration details including registrant information, province location (Guangdong), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
本产品适用于监控和评价广州万孚生物技术股份有限公司生产的B 型钠尿肽(BNP)测定试剂(干式荧光免疫一步法)检测时的质量控制.
本产品适用于监控和评价广州万孚生物技术股份有限公司生产的B 型钠尿肽（BNP）测定试剂（干式荧光免疫一步法）检测时的质量控制。
This product is a lyophilized powder, the main component is B-type natriuretic peptide (BNP) antigen.
本产品为冻干粉，主要成分为B型钠尿肽（BNP）抗原。
4℃～30℃密封避光保存,有效期为12个月.开盖复溶后在4℃～30℃可保存8小时,分装后可在-20℃条件下冻存28天,仅可冻融一次,不可反复冻融.
4℃～30℃密封避光保存，有效期为12个月。开盖复溶后在4℃～30℃可保存8小时，分装后可在-20℃条件下冻存28天，仅可冻融一次，不可反复冻融。